Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

A case of secondary renal amyloidosis complicating Crohn's disease

Jin GB, Yoon JS, Lee KT, Hwang EA, Han SY, Park SB, Kim HC

  • KMID: 2252414
  • Korean J Med.
  • 2006 Mar;70(3):309-312.
Secondary amyloidosis is characterized by accumulation of an amorphous proteineous material in the various tissue and orgrans with infectious or inflammatory disease. Renal amyloidosis in Crohn's disease is a rare...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiproliferative Effect of Phenylbutyrate in AsPC-1 Pancreatic Cancer Cell Line

Jin C, Park JW, Choi JW, Kang H, Jin GB, Choi SM, Park SS, Ryu D, Jang LC

  • KMID: 2244242
  • Korean J Hepatobiliary Pancreat Surg.
  • 2006 Mar;10(1):1-9.
PURPOSE: Phenylbutyrate is an effective redifferentiating agent in several human cancers. Recently phenylbutyrate has been reported to inhibit histone deacetylase activity. We investigated the effects of sodium 4-henylbutyrate (Na-4-PB) on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cyclooxygenase-2 Expression in Periampullary Cancer

Choi YJ, Jin GB, Jang LC, Park JW, Sung R, Choi JW

  • KMID: 2004548
  • J Korean Surg Soc.
  • 2003 Jul;65(1):49-54.
PURPOSE: Cyclooxygenase-2 (COX-2) expression is up-regulated in several types of human cancers and it has been suggested that COX-2 is closely inked to carcinogenesis. The objectives of this study were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term Prognosis of IgA Nephroapthy

Jin GB, Kim JE, Yoon JS, Sung JH, Kwak JH, Whang EA, Han SY, Park SB, Kim HC

  • KMID: 2079624
  • Korean J Nephrol.
  • 2006 May;25(3):365-373.
BACKGROUND: IgA nephropathy (IgAN) is the most frequent primary glomerulonephritis in the world. Despite 20 years of research into this condition, much remains unknown about its pathogenesis and therapy. One...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiproliferative Effect of NS-398, a Cyclooxygenase- 2 Inhibitor in TPC-1 Thyroid Cancer Cell Line

Jin GB, Park JW, Yun HY, Jang LC, Choi JW

PURPOSE: Cyclooxygenase (COX) enzymes catalyze the ratelimiting step in arachidonate metabolism. COX-1 is expressed constitutively in many cell types. However COX-2 is an inducible enzyme responsible for prostaglandin production at...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of Inducible Nitric Oxide Synthase (iNOS) in the Epithelial Cells of the Distended Bile Duct by the Bile Ductal Ligation

Park SS, Jin GB, Park JW, Jang LC, Sung RH, Choi JW

  • KMID: 2004555
  • J Korean Surg Soc.
  • 2003 May;64(5):365-371.
PURPOSE: Recent studies in an obstructive jaundice rat model showed that the bile duct epithelium is also very important in the bile duct dilatation besides the increased luminal pressure. This...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiproliferative Effect of NS-398, a Cyclooxygenase-2 Inhibitor, in Pancreatic Cancer Cell Lines.

Lee HD, Park JW, Choi JW, Kang H, Jin GB, Choi SM, Park SS, Jang LC

  • KMID: 2244243
  • Korean J Hepatobiliary Pancreat Surg.
  • 2006 Mar;10(1):10-20.
PURPOSE: Selective cyclooxygenase (COX)-2 inhibitors have been reported to inhibit cancer cell proliferation. We investigated the effects of NS-398, a selective COX-2 inhibitor, on cell proliferation in human pancreatic cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Paclitaxel-Coated Nylon Thread on the Proliferative Cholangitis in a Rat

Choi JW, Jin GB, Lee DG, Lee SJ, Jang LC, Sung R, Kim DW, Park SM

  • KMID: 2244296
  • Korean J Hepatobiliary Pancreat Surg.
  • 2003 Jun;7(1):77-86.
BACKGROUND/AIMS: Local drug delivery to the bile duct may be effective to prevent proliferative cholangitis (PC) through capability of high dose administeration with minimal systemic side effects. Paclitaxel is an...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr